118 related articles for article (PubMed ID: 15161658)
21. CD4 T-helper responses to the anaplastic lymphoma kinase (ALK) protein in patients with ALK-positive anaplastic large-cell lymphoma.
Ait-Tahar K; Barnardo MC; Pulford K
Cancer Res; 2007 Mar; 67(5):1898-901. PubMed ID: 17332315
[TBL] [Abstract][Full Text] [Related]
22. c-Jun expression and activation are restricted to CD30+ lymphoproliferative disorders.
Drakos E; Leventaki V; Schlette EJ; Jones D; Lin P; Medeiros LJ; Rassidakis GZ
Am J Surg Pathol; 2007 Mar; 31(3):447-53. PubMed ID: 17325487
[TBL] [Abstract][Full Text] [Related]
23. Apoptotic rate in peripheral T-cell lymphomas. A study using a tissue microarray with validation on full tissue sections.
Rassidakis GZ; Jones D; Thomaides A; Sen F; Lai R; Cabanillas F; McDonnell TJ; Medeiros LJ
Am J Clin Pathol; 2002 Sep; 118(3):328-34. PubMed ID: 12219774
[TBL] [Abstract][Full Text] [Related]
24. High expression of Mcl-1 in ALK positive and negative anaplastic large cell lymphoma.
Rust R; Harms G; Blokzijl T; Boot M; Diepstra A; Kluiver J; Visser L; Peh SC; Lim M; Kamps WA; Poppema S; van den Berg A
J Clin Pathol; 2005 May; 58(5):520-4. PubMed ID: 15858125
[TBL] [Abstract][Full Text] [Related]
25. Expression of anaplastic lymphoma kinase, tyrosine-phosphorylated STAT3, and associated factors in pediatric anaplastic large cell lymphoma: A report from the children's oncology group.
Nasr MR; Laver JH; Chang M; Hutchison RE
Am J Clin Pathol; 2007 May; 127(5):770-8. PubMed ID: 17439836
[TBL] [Abstract][Full Text] [Related]
26. Jak3 activation is significantly associated with ALK expression in anaplastic large cell lymphoma.
Lai R; Rassidakis GZ; Lin Q; Atwell C; Medeiros LJ; Amin HM
Hum Pathol; 2005 Sep; 36(9):939-44. PubMed ID: 16153455
[TBL] [Abstract][Full Text] [Related]
27. Restoration of shp1 expression by 5-AZA-2'-deoxycytidine is associated with downregulation of JAK3/STAT3 signaling in ALK-positive anaplastic large cell lymphoma.
Han Y; Amin HM; Frantz C; Franko B; Lee J; Lin Q; Lai R
Leukemia; 2006 Sep; 20(9):1602-9. PubMed ID: 16871283
[TBL] [Abstract][Full Text] [Related]
28. [Co-expression of CD99/MIC2 and ALK in anaplastic large-cell lymphoma tissues and its significance].
Zhong L; Wei QZ; Huang XP; Ji TH; Li F; Wang ZQ; Li XZ; Liu JH; Zhao T
Zhonghua Xue Ye Xue Za Zhi; 2012 Mar; 33(3):173-6. PubMed ID: 22781601
[TBL] [Abstract][Full Text] [Related]
29. The NADPH oxidase NOX5 protects against apoptosis in ALK-positive anaplastic large-cell lymphoma cell lines.
Carnesecchi S; Rougemont AL; Doroshow JH; Nagy M; Mouche S; Gumy-Pause F; Szanto I
Free Radic Biol Med; 2015 Jul; 84():22-29. PubMed ID: 25797883
[TBL] [Abstract][Full Text] [Related]
30. Caspase-3 activation in systemic anaplastic large-cell lymphoma.
Drakos E; Rassidakis GZ; Lai R; Herling M; O'Connor SL; Schmitt-Graeff A; McDonnell TJ; Medeiros LJ
Mod Pathol; 2004 Jan; 17(1):109-16. PubMed ID: 14657946
[TBL] [Abstract][Full Text] [Related]
31. Molecular cytogenetic aberrations in CD30+ anaplastic large cell lymphoma cell lines.
Gogusev J; Telvi L; Nezelof C
Cancer Genet Cytogenet; 2002 Oct; 138(2):95-101. PubMed ID: 12505251
[TBL] [Abstract][Full Text] [Related]
32. Altered expression of the retinoblastoma gene product in human high grade non-Hodgkin's lymphomas.
Weide R; Tiemann M; Pflüger KH; Köppler H; Parvizl B; Wacker HH; Kreipe HH; Havemann K; Parwaresch MR
Leukemia; 1994 Jan; 8(1):97-101. PubMed ID: 8289506
[TBL] [Abstract][Full Text] [Related]
33. Identification of anaplastic lymphoma kinase as a potential therapeutic target in ovarian cancer.
Ren H; Tan ZP; Zhu X; Crosby K; Haack H; Ren JM; Beausoleil S; Moritz A; Innocenti G; Rush J; Zhang Y; Zhou XM; Gu TL; Yang YF; Comb MJ
Cancer Res; 2012 Jul; 72(13):3312-23. PubMed ID: 22570254
[TBL] [Abstract][Full Text] [Related]
34. CD30-induced up-regulation of the inhibitor of apoptosis genes cIAP1 and cIAP2 in anaplastic large cell lymphoma cells.
Hübinger G; Schneider C; Stöhr D; Ruff H; Kirchner D; Schwänen C; Schmid M; Bergmann L; Müller E
Exp Hematol; 2004 Apr; 32(4):382-9. PubMed ID: 15050749
[TBL] [Abstract][Full Text] [Related]
35. Loss of heterozygosity for Rb locus and pRb immunostaining in laryngeal cancer: a clinicopathologic, molecular and immunohistochemical study.
Pietruszewska W; Klatka J; Borzecki A; Rieske P
Folia Histochem Cytobiol; 2008; 46(4):479-85. PubMed ID: 19141402
[TBL] [Abstract][Full Text] [Related]
36. Identification and validation of the anaplastic large cell lymphoma signature.
Piva R; Pellegrino E; Inghirami G
Adv Exp Med Biol; 2007; 604():129-36. PubMed ID: 17695725
[TBL] [Abstract][Full Text] [Related]
37. Loss of retinoblastoma gene function and heterozygosity at the RB locus in renal cortical neoplasms.
Lai S; Benedict WF; Silver SA; El-Naggar AK
Hum Pathol; 1997 Jun; 28(6):693-7. PubMed ID: 9191003
[TBL] [Abstract][Full Text] [Related]
38. Loss of heterozygosity occurs centromeric to RB without associated abnormalities in the retinoblastoma gene in tumors from patients with metastatic renal cell carcinoma.
Walther MM; Gnarra JR; Elwood L; Xu HJ; Florence C; Anglard P; Hu SX; King C; Trahan E; Hurley K
J Urol; 1995 Jun; 153(6):2050-4. PubMed ID: 7752392
[TBL] [Abstract][Full Text] [Related]
39. Detection of differentially expressed genes in lymphomas using cDNA arrays: identification of clusterin as a new diagnostic marker for anaplastic large-cell lymphomas.
Wellmann A; Thieblemont C; Pittaluga S; Sakai A; Jaffe ES; Siebert P; Raffeld M
Blood; 2000 Jul; 96(2):398-404. PubMed ID: 10887098
[TBL] [Abstract][Full Text] [Related]
40. Abundance and state of phosphorylation of the retinoblastoma gene product in human pituitary tumors.
Woloschak M; Yu A; Xiao J; Post KD
Int J Cancer; 1996 Jul; 67(1):16-9. PubMed ID: 8690518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
